This inventor holds 8 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 13 EPO patents. Top assignees: Carl Freudenberg Kg, Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh, Aesculap Ag. Active years: 2005-2020.
Company Filing History:
6 out of 538 
2 out of 24 
1 out of 585 
Years Active: 2005-2020
Title: The Innovative Contributions of Denis Reibel
Introduction
Denis Reibel is a notable inventor based in Herrlisheim, France, recognized for his significant contributions to the field of medical devices. With a total of eight patents to his name, Reibel has made strides in developing advanced solutions for wound care and bioresorbable materials.
Latest Patents
Among his latest innovations is a medical device that features a nonwoven wound dressing made from rotospun fibers. This device incorporates at least one synthetic and bioabsorbable polymer along with a hydrophilic and/or tissue-adhesive polymer. The method of producing this medical device utilizes rotospinning to create fibers from a fiber raw material that includes these polymers. Another significant patent is for a bioresorbable nonwoven fabric made of gelatin. This fabric consists of fibers that may include an antimicrobially effective substance and an antibiotic, produced through rotational spinning.
Career Highlights
Throughout his career, Denis Reibel has worked with prominent companies such as Carl Freudenberg KG and Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH. His experience in these organizations has contributed to his expertise in the development of innovative medical technologies.
Collaborations
Reibel has collaborated with talented professionals in his field, including Dirk Grafahrend and Daniel Neumüller. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.
Conclusion
Denis Reibel's work in the medical device sector showcases his commitment to innovation and improving patient care through advanced materials. His patents reflect a deep understanding of the needs in wound management and bioresorbable technologies.